GlassScriptPhysician profile
Raquel I Velazquez
NPI 1700351871
$584.54
in general payments reported to CMS, 2019-2025
14 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $35.51 · 2024: $29.39 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $208.81 | 2025 | Spinejack, Optablate |
| Amgen INC. | $69.97 | 2021 | |
| Merck Sharp & Dohme LLC | $42.46 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.51 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.66 | 2021 | |
| Ucb, INC. | $29.39 | 2024 | Briviact |
| Microtransponder, INC. | $25.00 | 2025 | |
| Ebi, LLC | $24.41 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Vertex Pharmaceuticals Incorporated | $24.06 | 2025 | |
| Boston Scientific Corporation | $22.52 | 2025 | General - Pain Management |
| Cvrx, INC. | $22.02 | 2025 | Barostim Neo System |
| Davol INC. | $19.84 | 2025 | Avitene Ultrafoam |
| Mimedx Group, INC. | $16.80 | 2025 | |
| Esperion Therapeutics, INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raquel Velazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.